Logo image of OSS

ONE STOP SYSTEMS INC (OSS) Stock Fundamental Analysis

USA - NASDAQ:OSS - US68247W1099 - Common Stock

5.61 USD
-0.69 (-10.95%)
Last: 10/16/2025, 6:54:54 PM
5.71 USD
+0.1 (+1.78%)
After Hours: 10/16/2025, 6:54:54 PM
Fundamental Rating

3

Overall OSS gets a fundamental rating of 3 out of 10. We evaluated OSS against 33 industry peers in the Technology Hardware, Storage & Peripherals industry. While OSS has a great health rating, there are worries on its profitability. OSS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OSS had negative earnings in the past year.
In the past year OSS has reported a negative cash flow from operations.
OSS had negative earnings in 4 of the past 5 years.
In the past 5 years OSS reported 4 times negative operating cash flow.
OSS Yearly Net Income VS EBIT VS OCF VS FCFOSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

The Return On Assets of OSS (-38.57%) is worse than 81.82% of its industry peers.
Looking at the Return On Equity, with a value of -54.94%, OSS is in line with its industry, outperforming 42.42% of the companies in the same industry.
Industry RankSector Rank
ROA -38.57%
ROE -54.94%
ROIC N/A
ROA(3y)-18.26%
ROA(5y)-10.06%
ROE(3y)-24.06%
ROE(5y)-13.33%
ROIC(3y)N/A
ROIC(5y)N/A
OSS Yearly ROA, ROE, ROICOSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

OSS has a worse Gross Margin (14.72%) than 75.76% of its industry peers.
In the last couple of years the Gross Margin of OSS has declined.
OSS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.63%
GM growth 5Y-15.76%
OSS Yearly Profit, Operating, Gross MarginsOSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

8

2. Health

2.1 Basic Checks

OSS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSS has more shares outstanding
Compared to 5 years ago, OSS has more shares outstanding
The debt/assets ratio for OSS has been reduced compared to a year ago.
OSS Yearly Shares OutstandingOSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
OSS Yearly Total Debt VS Total AssetsOSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

OSS has an Altman-Z score of 7.55. This indicates that OSS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.55, OSS belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
There is no outstanding debt for OSS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.55
ROIC/WACCN/A
WACC8.64%
OSS Yearly LT Debt VS Equity VS FCFOSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

OSS has a Current Ratio of 3.42. This indicates that OSS is financially healthy and has no problem in meeting its short term obligations.
OSS's Current ratio of 3.42 is amongst the best of the industry. OSS outperforms 81.82% of its industry peers.
A Quick Ratio of 1.84 indicates that OSS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.84, OSS is doing good in the industry, outperforming 75.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 1.84
OSS Yearly Current Assets VS Current LiabilitesOSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

OSS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -273.33%.
OSS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.19%.
OSS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.27% yearly.
EPS 1Y (TTM)-273.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)-10.19%
Revenue growth 3Y-4.08%
Revenue growth 5Y-1.27%
Sales Q2Q%6.88%

3.2 Future

Based on estimates for the next years, OSS will show a very strong growth in Earnings Per Share. The EPS will grow by 46.52% on average per year.
Based on estimates for the next years, OSS will show a quite strong growth in Revenue. The Revenue will grow by 11.79% on average per year.
EPS Next Y88.98%
EPS Next 2Y46.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.77%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OSS Yearly Revenue VS EstimatesOSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
OSS Yearly EPS VS EstimatesOSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

OSS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
OSS is valuated quite expensively with a Price/Forward Earnings ratio of 69.43.
Based on the Price/Forward Earnings ratio, OSS is valued a bit more expensive than the industry average as 63.64% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.85, OSS is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 69.43
OSS Price Earnings VS Forward Price EarningsOSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSS Per share dataOSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

OSS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OSS's earnings are expected to grow with 46.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.52%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONE STOP SYSTEMS INC

NASDAQ:OSS (10/16/2025, 6:54:54 PM)

After market: 5.71 +0.1 (+1.78%)

5.61

-0.69 (-10.95%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-06 2025-11-06/amc
Inst Owners35.09%
Inst Owner Change0%
Ins Owners4.08%
Ins Owner Change0.54%
Market Cap122.97M
Analysts80
Price Target8.16 (45.45%)
Short Float %0.48%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-663.37%
Min EPS beat(2)-1288.12%
Max EPS beat(2)-38.61%
EPS beat(4)0
Avg EPS beat(4)-454.95%
Min EPS beat(4)-1288.12%
Max EPS beat(4)-38.61%
EPS beat(8)3
Avg EPS beat(8)-240.78%
EPS beat(12)3
Avg EPS beat(12)-207.59%
EPS beat(16)6
Avg EPS beat(16)-150.48%
Revenue beat(2)0
Avg Revenue beat(2)-2.24%
Min Revenue beat(2)-4.41%
Max Revenue beat(2)-0.07%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-4.41%
Max Revenue beat(4)1.84%
Revenue beat(8)5
Avg Revenue beat(8)-0.43%
Revenue beat(12)8
Avg Revenue beat(12)-0.23%
Revenue beat(16)11
Avg Revenue beat(16)0.21%
PT rev (1m)14.29%
PT rev (3m)77.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 69.43
P/S 2.26
P/FCF N/A
P/OCF N/A
P/B 4.72
P/tB 5.01
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)0.08
Fwd EY1.44%
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS2.48
BVpS1.19
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.57%
ROE -54.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.72%
FCFM N/A
ROA(3y)-18.26%
ROA(5y)-10.06%
ROE(3y)-24.06%
ROE(5y)-13.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.63%
GM growth 5Y-15.76%
F-Score3
Asset Turnover1.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.67%
Cap/Sales 0.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.42
Quick Ratio 1.84
Altman-Z 7.55
F-Score3
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)50.77%
Cap/Depr(5y)48.28%
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-273.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y88.98%
EPS Next 2Y46.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.19%
Revenue growth 3Y-4.08%
Revenue growth 5Y-1.27%
Sales Q2Q%6.88%
Revenue Next Year10.77%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-317.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.67%
OCF growth 3YN/A
OCF growth 5YN/A